Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Liabilities (2018 - 2025)

AVITA Medical (RCEL) has disclosed Total Liabilities for 6 consecutive years, with $73.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 2.57% year-over-year to $73.0 million, compared with a TTM value of $73.0 million through Dec 2025, down 2.57%, and an annual FY2025 reading of $73.0 million, down 2.57% over the prior year.
  • Total Liabilities was $73.0 million for Q4 2025 at AVITA Medical, up from $70.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $75.0 million in Q4 2024 and bottomed at $8.7 million in Q1 2022.
  • Average Total Liabilities over 4 years is $44.6 million, with a median of $62.7 million recorded in 2023.
  • The sharpest move saw Total Liabilities skyrocketed 377.3% in 2023, then dropped 2.57% in 2025.
  • Year by year, Total Liabilities stood at $13.0 million in 2022, then surged by 377.3% to $61.9 million in 2023, then rose by 21.13% to $75.0 million in 2024, then fell by 2.57% to $73.0 million in 2025.
  • Business Quant data shows Total Liabilities for RCEL at $73.0 million in Q4 2025, $70.4 million in Q3 2025, and $71.0 million in Q2 2025.